Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $137.1 million.

  • Dexcom's Other Non-Current Liabilities fell 730.22% to $137.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $137.1 million, marking a year-over-year decrease of 730.22%. This contributed to the annual value of $137.1 million for FY2025, which is 730.22% down from last year.
  • Latest data reveals that Dexcom reported Other Non-Current Liabilities of $137.1 million as of Q4 2025, which was down 730.22% from $147.4 million recorded in Q3 2025.
  • Over the past 5 years, Dexcom's Other Non-Current Liabilities peaked at $151.6 million during Q2 2025, and registered a low of $82.4 million during Q1 2021.
  • Over the past 5 years, Dexcom's median Other Non-Current Liabilities value was $128.8 million (recorded in 2022), while the average stood at $122.5 million.
  • In the last 5 years, Dexcom's Other Non-Current Liabilities soared by 29425.84% in 2021 and then plummeted by 730.22% in 2025.
  • Dexcom's Other Non-Current Liabilities (Quarter) stood at $90.0 million in 2021, then skyrocketed by 42.56% to $128.3 million in 2022, then fell by 2.1% to $125.6 million in 2023, then increased by 17.75% to $147.9 million in 2024, then fell by 7.3% to $137.1 million in 2025.
  • Its last three reported values are $137.1 million in Q4 2025, $147.4 million for Q3 2025, and $151.6 million during Q2 2025.